Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8237215 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 9 Pages |
Abstract
Dose reduction to specified structures during IMRT implies an increased beam path dose to alternate nontarget structures that may result in clinical toxicities that were uncommon with previous, less conformal approaches. These findings have implications for IMRT treatment planning and research, toxicity assessment, and multidisciplinary patient management.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David I. M.D., Mark S. D.M.D., Clifton D. M.D., Neal C.S. B.S., John C.M.D., Merrill S. M.D., William H. M.D., K. Kian M.D., Ph.D., Adam S. M.D.,